Cyber Swan Sale

50% Off Elite

00
Days
00
Hours
00
Mins
00
Sec
Register Now!

Get our most powerful screeners, new charting tools, and the fastest ad-free experience at our best price ever. One last chance.

Last Close
Dec 01  •  04:00PM ET
36.59
Dollar change
-1.24
Percentage change
-3.28
%
CategoryUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y38.87% Total Holdings112 Perf Week6.03%
SponsorVirtus ETF Solutions ETF Type Tagsequity Return% 3Y15.03% AUM26.40M Perf Month14.19%
Fund Family Bond Type Tagsbiotechnology Return% 5Y-2.89% NAV/sh Perf Quarter57.72%
IndexLifeSci Biotechnology Clinical Trials In... Average Maturity Tagsclinical-trials Return% 10Y 52W High37.83 -3.28% Perf Half Y92.48%
Index Weighting Commodity Type Tagsinnovation Return% SI 52W Low13.42 172.65% Perf YTD52.82%
Active/Passive Quant Type Tags- Flows% 1M7.46% Volatility2.63% 2.97% Perf Year34.18%
Dividend TTM0.24 (0.65%) ESG Type Tags- Flows% 3M2.54% ATR (14)1.07 Perf 3Y46.36%
Dividend Ex-DateDec 20, 2024 Dividend Type Sector/Theme Flows% YTD47.40% RSI (14)69.89 Perf 5Y-17.08%
Dividend Gr. 3/5Y- - Structure Type Region Flows% 1Y Beta0.92 Perf 10Y24.92%
Expense0.79% Growth/Value SMA2010.32% Flows% 3Y Rel Volume2.44 Prev Close37.83
Inverse/Leveraged Market Cap SMA5019.03% Flows% 5Y Avg Volume17.13K Price36.59
IPODec 17, 2014 Option/ShortYes / Yes SMA20060.41% Trades Volume40,913 Change-3.28%
Dec-01-25 06:00AM
Nov-25-25 03:44AM
Nov-24-25 10:00AM
Nov-17-25 07:43AM
Oct-30-25 09:00AM
05:00AM Loading…
Oct-28-25 05:00AM
Oct-20-25 06:00AM
Oct-16-25 06:51AM
Sep-10-25 09:49AM
Sep-09-25 07:00AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-28-25 04:26AM
Apr-23-25 05:45AM
Apr-21-25 08:00AM
01:40PM Loading…
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-23-25 07:18AM
Mar-20-25 04:32PM
Oct-31-24 05:32PM
Aug-30-21 04:00PM
Aug-20-20 05:25PM
04:54PM
May-27-20 09:40AM
May-11-20 01:00PM
Feb-10-20 01:40PM
08:00AM Loading…
Dec-31-19 08:00AM
Dec-27-19 02:19PM
11:59AM
12:30AM
Dec-26-19 02:30PM
Dec-24-19 12:15PM
Dec-23-19 12:00PM
10:10AM
Dec-20-19 02:00PM
Dec-18-19 01:41PM
Dec-17-19 03:31PM
Dec-16-19 10:42AM
Dec-12-19 08:00AM
Dec-10-19 04:16PM
10:10AM
Dec-04-19 09:40AM
Dec-03-19 02:30PM
Dec-02-19 11:10AM
Nov-29-19 12:15PM
Nov-25-19 08:00AM
Nov-21-19 12:56PM
12:15PM
Nov-04-19 10:10AM
Oct-30-19 10:43AM
Oct-23-19 10:10AM
Apr-25-19 10:00AM
Mar-12-19 11:05AM
Dec-27-18 02:30PM
Dec-21-18 02:30PM
Dec-18-18 10:55AM
Nov-20-18 10:25AM
Oct-23-18 09:18AM
Sep-04-18 01:00PM
Jul-12-18 04:53PM
Jul-10-18 12:15PM
Jul-09-18 02:37PM
May-15-18 12:15PM
Apr-18-18 04:08PM
Mar-14-18 05:39PM
Feb-02-18 08:00AM
Dec-25-17 06:00AM
Dec-22-17 04:16PM
Dec-19-17 03:00PM
Sep-11-17 10:29AM
Aug-30-17 01:08PM
Aug-28-17 02:37PM
Jun-30-17 11:30AM
Jun-29-17 03:37PM
02:33PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 08:00AM
May-15-17 03:26PM
Apr-28-17 09:30AM
Apr-27-17 10:03AM
Apr-03-17 10:59AM
Mar-31-17 09:30AM
Mar-30-17 11:22AM
Mar-29-17 10:09AM
Mar-22-17 10:51AM
Mar-21-17 12:19PM
Mar-08-17 10:07AM
Mar-01-17 01:24PM
08:59AM
Feb-28-17 12:00PM
Jan-12-17 10:08AM
Jan-11-17 06:54AM
Jan-03-17 10:36AM
Dec-30-16 07:02AM
Dec-27-16 10:42PM
Virtus LifeSci Biotech Clinical Trials ETF seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.